There were no significant differences between the expression of either MYC or TRPS1 in BPH, untreated and hormone-refractory carcinomas, suggesting that alterations in the expression of these two genes are not generally involved in the progression of prostate cancer. The gene discussed is TRPS1; the disease is Familial prostate cancer.